NEXMAB
Pharmaceuticals, namely, monoclonal antibodies and fragments therefor for therapeutic purposes, namely the treatment and diagnosis of cancer, proliferative cell diseases, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases
Abandoned · January 5, 2007 · 77076778 ·